Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
14.38
+0.26 (1.84%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Vor Biopharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Net Income
-695.98-116.91-117.86-92.09-68.9
Upgrade
Depreciation & Amortization
2.893.533.492.531.43
Upgrade
Loss (Gain) From Sale of Assets
3.3-0.02---
Upgrade
Asset Writedown & Restructuring Costs
177.38----
Upgrade
Stock-Based Compensation
18.919.8513.3610.74.32
Upgrade
Other Operating Activities
340.583.890.073.573.19
Upgrade
Change in Accounts Payable
10.932.242.851.110.41
Upgrade
Change in Other Net Operating Assets
-0.72-2.24-2.2-10.95-9.59
Upgrade
Operating Cash Flow
-142.71-99.66-100.29-85.14-69.14
Upgrade
Capital Expenditures
-0.94-0.23-1.07-8.46-3.89
Upgrade
Sale of Property, Plant & Equipment
0.8----
Upgrade
Investment in Securities
-48.6697.0972.08-85.63-87.76
Upgrade
Investing Cash Flow
-48.896.8671.01-94.09-91.65
Upgrade
Issuance of Common Stock
505.3956.054.84117.14189.75
Upgrade
Repurchase of Common Stock
-0.25-0.33-1.19--
Upgrade
Other Financing Activities
-1.33-2.33-0.72--2.22
Upgrade
Financing Cash Flow
503.8153.392.94117.14232.91
Upgrade
Net Cash Flow
312.2950.59-26.35-62.172.12
Upgrade
Free Cash Flow
-143.65-99.89-101.36-93.61-73.04
Upgrade
Free Cash Flow Per Share
-14.55-29.07-30.17-47.33-43.69
Upgrade
Levered Free Cash Flow
-180.67-60.89-58.02-51.87-48.67
Upgrade
Unlevered Free Cash Flow
-180.67-60.89-58.02-51.87-48.67
Upgrade
Change in Working Capital
10.210.010.65-9.84-9.19
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.